Vaccination News

The FDA has granted approval to Pfizer-BioNTech’s COVID-19 vaccine Comirnaty for use in adolescents aged 12 to 15 years, according to a company press release.

It is finally possible to eliminate hepatitis B virus in the United States, as long as a multipronged strategy is used to fully implement new guidance that recommends universal vaccination for adults aged 19 to 59 years, experts said.

The White House recently announced plans to expand monkeypox vaccination eligibility in the United States.

A survey conducted last fall found that around half of parents of children aged 0 to 4 years said they were likely to vaccinate their children against COVID-19, researchers reported.

The FDA has told COVID-19 vaccine manufacturers that they should add omicron BA.4 and BA.5 variants to their existing vaccines to create bivalent boosters.

U.S. health officials announced a new plan to broaden access to monkeypox vaccines amid a continued rise in cases.

An FDA advisory committee voted Tuesday to recommend changing the composition of COVID-19 booster vaccines to include the addition of the omicron variant of SARS-CoV-2 as a component.

A recent study showed that Paxlovid was associated with a 46% reduction in severe COVID-19 or death among high-risk patients. It was the top story in infectious disease last week.

Infants aged younger than 6 months were better protected from serious COVID-19 outcomes if their mothers received two doses of the vaccine while pregnant, according to researchers.

Healio Pediatrics Editorial Board Member Leonard R. Krilov, MD, FAAP, FIDSA, FPIDS, chief of pediatric infectious diseases at NYU Langone Hospital – Long Island, answers some frequently asked questions about the vaccines.